Enclomiphene vs TRT: which should I consider first?

Short answer: start by clarifying your goals and lab pattern. If you want to preserve (or improve) fertility and you have secondary/central hypogonadism, try a gonadotropin-stimulating approach (enclomiphene or, more commonly, clomiphene) first. If you have primary testicular failure, are older and don’t want fertility, or need fast, predictable symptom control, consider testosterone replacement therapy (TRT).

Key points to help decide

• Goal: fertility vs symptom relief

  • Fertility desired: avoid standard TRT because it suppresses LH/FSH and sperm production. Enclomiphene (or clomiphene) stimulates the HPT axis and is the preferred first option.
  • Fertility not desired and you want reliable symptom control (energy, libido, muscle mass): TRT is often preferred.

• Cause of low T (lab pattern)

  • Secondary/central hypogonadism: low T with low/normal LH and FSH → a SERM (enclomiphene/clomiphene) or hCG may restore endogenous testosterone and preserve sperm. Good first-line choice.
  • Primary hypogonadism: low T with high LH/FSH → testes likely won’t respond; TRT is usually the right choice.

• Age and comorbidities

  • Younger men and men trying to father kids: favor HPT-stimulating therapy first.
  • Older men, men with markedly low testosterone and severe symptoms, or those with irreversible testicular failure: TRT is reasonable.

• Availability and evidence

  • Enclomiphene (brand name Androxal) has been studied for male hypogonadism but is not widely available/approved everywhere. Clomiphene citrate (Clomid) is commonly used off-label and has a long track record.
  • TRT formulations are well established, widely available, and FDA-approved.

Safety/monitoring differences

• Enclomiphene/clomiphene: may cause mood changes, visual symptoms in rare cases; requires monitoring of testosterone and sometimes LH/FSH and estradiol. Generally preserves or improves sperm count.
• TRT: can improve symptoms reliably but suppresses spermatogenesis, can raise hematocrit, affect lipids, and needs PSA/hematocrit monitoring and periodic testosterone checks.

Practical options (brands/services)

• If considering enclomiphene/clomiphene:
  • Clomiphene citrate (Clomid) — widely used off-label for men; familiar to many clinicians and easier to obtain.
  • Enclomiphene (Androxal) — studied specifically for men but availability/approval varies by country.
• If considering TRT:
  • Gels: AndroGel, Testim — daily application, convenient but risk of transfer to others.
  • Patches: Androderm — daily patch option.
  • Injections: Depo-Testosterone (testosterone cypionate), Delatestryl/testosterone enanthate — common, cost-effective IM injections. Long-acting IM: Aveed (testosterone undecanoate) / Nebido (outside US) for less frequent dosing.
  • Pellets: Testopel — implanted pellets that last months.
• Telemedicine/clinic services (for consultation, labs, prescriptions, monitoring):
  • Vault Health, Defy Medical — focused on men’s hormone care and specialist-driven monitoring.
  • Roman, Hims — consumer-friendly telehealth options (more convenient but choose one that provides proper labs and specialty follow-up).
  • For fertility concerns, see a reproductive endocrinologist or urologist/andrologist.

What to do next

1. Get baseline labs (morning total testosterone — 8–10 AM on at least two occasions — plus LH, FSH, prolactin, estradiol, SHBG as indicated; CBC, CMP, lipid panel, PSA if older).
2. Share results with an endocrinologist, urologist, or a reputable men’s-health clinic (Vault, Defy, or a local specialist) to choose the right therapy.
3. If fertility is a priority and labs show secondary hypogonadism, discuss clomiphene/enclomiphene or hCG first. If primary hypogonadism or severe symptoms and no desire for fertility, discuss TRT options and monitoring.

If you’d like, tell me your age, whether you want children, and any lab results or symptoms — I can help interpret them and suggest a practical next step.